Auto Injectors: Customer needs and future trends

Pharmaceutical industry might well be one of the most exacting industries on the market. In order to satisfy a very broad range of stakeholders, including patients, prescribers, payers, patient-care providers and other healthcare professionals,...

EU-wide IP Expertise is essential to the life science industry post-Brexit

The UK is world-renowned for its progressive life science and healthcare sectors, which are at the forefront of technical innovation, research excellence, and pioneering treatments. Life science companies, research and development facilities, scientists and academics...

How do bioscience companies ensure a strong talent pipeline for the future?

The UK science industry is facing a national shortage of highly skilled workers, an issue linked previously to STEM subjects being a less favourable option at A Level. But the tides are changing; this year...

How to protect your IP rights in Europe

Intellectual property rights are territorial rights, meaning that the protection afforded by a granted patent or a registered trademark is geographically limited. Many companies that protect their inventions, brands or product designs in their home...

The Age of Cell Therapy Industry that takes advantage of pioneering research

For a cutting-edge technology, cell therapy has a surprisingly long history. Indeed, the idea of injecting living cells into a patient originated in the nineteenth century. Although scientists’ early rudimentary attempts did not really work,...

Research deepens understanding of malaria parasite

Science carried out in Nottingham helped to form the foundation for the latest breakthrough in the global fight against malaria. Researchers in the University of Nottingham’s School of Life Sciences were responsible for the identification...

Will Man ever run the 100m in less than nine seconds? *

It is never easy to run 100m in less than ten seconds, as the recent Commonwealth Games demonstrated. However, as the world record stands at 9.58 seconds, the attention in recent years has turned...

Cell line technology

By Frances Griss One of the most exciting and rapidly growing fields of bioscience is the development of new cell lines with specific and controllable characteristics, either for research or industrial scale production. Companies all over...

Aiming high and encouraging young people into the world of science

Talk to anyone in the bioscience world and they will tell you that one of their major concerns is the dearth of young people coming out of schools, colleges and universities having studied science...

Surface research could help control infection

Another front in the war against infection is the introduction of antimicrobial surfaces into hospitals. By making the environment more hostile to pathogens such as Clostridium difficile and Staphilococcus aureus there will be less...

An insight into the Cambridge economy – what lies ahead for Silicon Fen?

Dr Andy Cosh & Dr Giorgio Caselli - Centre for Business Research & University of Cambridge These are rather frantic days for the UK, since several outcomes remain possible following the Brexit referendum in June 2016. While the government...

Better understanding of immunology offers hope for the future

Recent years have seen dramatic strides being taken in the science of immunology – the capacity to direct the body’s natural defences against specific illnesses and conditions. So dramatic have the strides been that scientists’...

Patent Protection of Medical Devices – Time for a Rethink?

Christopher Burnett,  Patent Attorney,  AA Thornton The duration of patent protection for medical devices is up to twenty years, as for any other type of device. Pharmaceuticals, on the other hand, may be entitled to an...

Cell therapy manufacturing –making the future now

There is no mistaking the sure but steady revolution happening in cell therapy.  With the long-held promise now rewarded with greater funding, investment and belief, the change in gear has been dizzying. However, this is...

Research at the interface of technology and life sciences

Professor Jens Jordan, Director of the Institute of Aerospace Medicine The Institute of Aerospace Medicine at the German Aerospace Center (DLR) comprises departments in Cologne and in Hamburg with internationally unique research infrastructure. At DLR, the...

Biosimilars and Patents

Leonita Paulraj - Associate, AA Thornton The majority of the world’s biggest selling medicines can be classified as “biologics” or “biopharmaceuticals”. Such medicines contain one or more biologically active product produced from (or containing components of)...